1. Home
  2. HSHP vs OSUR Comparison

HSHP vs OSUR Comparison

Compare HSHP & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSHP
  • OSUR
  • Stock Information
  • Founded
  • HSHP 2021
  • OSUR 2000
  • Country
  • HSHP Bermuda
  • OSUR United States
  • Employees
  • HSHP N/A
  • OSUR N/A
  • Industry
  • HSHP
  • OSUR Medical/Dental Instruments
  • Sector
  • HSHP
  • OSUR Health Care
  • Exchange
  • HSHP Nasdaq
  • OSUR Nasdaq
  • Market Cap
  • HSHP 282.3M
  • OSUR 319.9M
  • IPO Year
  • HSHP 2023
  • OSUR 1986
  • Fundamental
  • Price
  • HSHP $7.09
  • OSUR $4.35
  • Analyst Decision
  • HSHP
  • OSUR Buy
  • Analyst Count
  • HSHP 0
  • OSUR 3
  • Target Price
  • HSHP N/A
  • OSUR $6.67
  • AVG Volume (30 Days)
  • HSHP 117.2K
  • OSUR 475.9K
  • Earning Date
  • HSHP 01-01-0001
  • OSUR 11-06-2024
  • Dividend Yield
  • HSHP 6.06%
  • OSUR N/A
  • EPS Growth
  • HSHP N/A
  • OSUR N/A
  • EPS
  • HSHP 0.58
  • OSUR 0.15
  • Revenue
  • HSHP $112,303,000.00
  • OSUR $224,263,000.00
  • Revenue This Year
  • HSHP $284.85
  • OSUR N/A
  • Revenue Next Year
  • HSHP $16.28
  • OSUR N/A
  • P/E Ratio
  • HSHP $12.66
  • OSUR $29.26
  • Revenue Growth
  • HSHP 919.64
  • OSUR N/A
  • 52 Week Low
  • HSHP $4.51
  • OSUR $3.92
  • 52 Week High
  • HSHP $9.76
  • OSUR $8.45
  • Technical
  • Relative Strength Index (RSI)
  • HSHP 47.33
  • OSUR 52.53
  • Support Level
  • HSHP $6.79
  • OSUR $4.06
  • Resistance Level
  • HSHP $7.21
  • OSUR $4.29
  • Average True Range (ATR)
  • HSHP 0.17
  • OSUR 0.14
  • MACD
  • HSHP 0.06
  • OSUR 0.03
  • Stochastic Oscillator
  • HSHP 76.40
  • OSUR 38.33

About HSHP Himalaya Shipping Ltd.

Himalaya Shipping Ltd is an independent dry bulk company that focuses on owning and operating its Newcastlemax dry bulk carriers.

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

Share on Social Networks: